Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ECT 204

Next Previous
Search
Drug Profile

ECT 204

Alternative Names: ECT-204; ECT204 ARTEMIS® T cell therapy - Eureka Therapeutics; ECT204 T cells - Eureka Therapeutics; ECT204 T-cell therapy - Eureka Therapeutics; GPC3 targeting ARTEMIS® T-cell therapy - Eureka Therapeutics; GPC3 targeting T-cell therapy - Eureka Therapeutics; JWATM-204; JWCAR-204

Latest Information Update: 06 Sep 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Eureka Therapeutics
  • Developer Eureka Therapeutics; JW Therapeutics
  • Class Antineoplastics; Gene therapies; Immunotherapies; T lymphocyte cell therapies
  • Mechanism of Action Immunologic cytotoxicity; T lymphocyte replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Liver cancer
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase I/II Liver cancer
  • Preclinical Adenocarcinoma; Non-small cell lung cancer

Most Recent Events

  • 06 Sep 2022 Preclinical trials in Adenocarcinoma in China (Parenteral) prior to September 2022 (JW Therapeutics website, September 2022)
  • 06 Sep 2022 Preclinical trials in Non-small cell lung cancer in China (Parenteral) prior to September 2022 (JW Therapeutics website, September 2022)
  • 06 Jul 2022 ECT 204 licensed to JW Therapeutics in China (mainland China, Hong Kong, Macao and Taiwan) and the member countries of the Association of Southeast Asian Nations

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top